Product
Intranasal OXT
1 clinical trial
1 indication
Indication
Central Diabetes Insipidus (cDI)Clinical trial
Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus: a Double-blind Randomised Placebo-controlled Trial: the OxyTUTION TrialStatus: Recruiting, Estimated PCD: 2026-10-01